Target Validation Information
Target ID T38301
Target Name Ribonucleoside-diphosphatereductase subunit M2
Target Type
Successful
Drug Potency against Target Motexafin gadolinium Drug Info IC50 = 6 microM [536181]
References
Ref 536181Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. J Biol Chem. 2006 Apr 21;281(16):10691-7. Epub 2006 Feb 14.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.